Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
Fennec Pharmaceuticals Inc. (FENC)
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.fennecpharma.com/investor-relations
Company Research
Source: Yahoo! Finance
General and Administrative Expenses: $6.1 million for Q3 2024, compared to $3.8 million in Q3 2023. Selling and Marketing Expenses: $4.6 million for Q3 2024, compared to $3.4 million in Q3 2023. Cash Position: Approximately $40.3 million in cash, cash equivalents, and investment securities as of the end of Q3 2024. Warning! GuruFocus has detected 3 Warning Signs with FENC. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Fennec Pharmaceuticals Inc ( NASDAQ:FENC ) reported net product sales of $7.0 million for the third quarter of 2024, an increase from $6.5 million in the same quarter of 2023. The company has achieved over 90% reimbursement for Pedmark in the adolescent and young adult (AYA) population, indicating strong market acceptance. Fennec Pharmaceuticals Inc ( NASDAQ:FENC ) has strengthened its leadership team with the appointment of experienced executives, which is expected to
Show less
Read more
Impact Snapshot
Event Time:
FENC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FENC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FENC alerts
High impacting Fennec Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
FENC
News
- Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Stephens to a "strong-buy" rating.MarketBeat
- Fennec Pharmaceuticals to Participate in Upcoming Investor ConferenceGlobeNewswire
- Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
FENC
Earnings
- 11/7/24 - Miss
FENC
Sec Filings
- 11/18/24 - Form 4
- 11/14/24 - Form SCHEDULE
- 11/13/24 - Form 4
- FENC's page on the SEC website